An experimental product made from the skin of tissue donors and processed to remove the donors' cells has healed chronic leg ulcers in more than half of the participants and decreased wound size in others involved in a clinical trial, the U.K. National Health Service reported. The product serves as a scaffold for cells to regenerate living, functional skin tissue and did not cause immune-system rejection.

Full Story:
MTB Europe

Related Summaries